Recyclable Curcumin-Based Bioepoxy Resin with On-Demand Chemical Cleavability.

We synthesized a novel curcumin-based bioepoxy resin by introducing epichlorohydrin (ECH) into the hydroxyl groups of curcumin and analyzed it using Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR). The epoxy equivalent weight (EEW) was determined based on a reaction with sodium hydroxide (NaOH) through titration, and the actual curing process was conducted after exploring the optimal conditions using an amine-based curing agent through dynamic scanning in differential scanning calorimetry (DSC) and isotherm analysis. The cured epoxy resin had a tensile strength, Young's modulus, and glass transition temperature (Tg) of 33 MPa, 1.4 GPa, and 86 °C, respectively. Interestingly, the diunsaturated ketone contained in the epoxy resin showed on-demand chemical cleavability, in that it had been decomposed into an aldehyde and ketone only after having been converted to a hydroxyl ketone through an oxidation reaction. The results of this study can significantly contribute to improving the eco-friendliness and recyclability of epoxy resins used in fields requiring long-term stability and chemical resistance.

Inhibiting peripheral and central MAO-B ameliorates joint inflammation and cognitive impairment in rheumatoid arthritis.

Rheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic inflammation and the destruction of joints and systemic organs. RA is commonly accompanied by neuropsychiatric complications, such as cognitive impairment and depression. However, the role of monoamine oxidase (MAO) and its inhibitors in controlling neurotransmitters associated with these complications in RA have not been clearly identified. Here, we report that peripheral and central MAO-B are highly associated with joint inflammation and cognitive impairment in RA, respectively. Ribonucleic acid (RNA) sequencing and protein expression quantification were used to show that MAO-B and related molecules, such as gamma aminobutyric acid (GABA), were elevated in the inflamed synovium of RA patients. In primary cultured fibroblast-like synoviocytes in the RA synovium, MAO-B expression was significantly increased by tumor necrosis factor (TNF)-α-induced autophagy, which produces putrescine, the polyamine substrate for GABA synthesis. We also observed that MAO-B-mediated aberrant astrocytic production of GABA was augmented by interleukin (IL)-1ß and inhibited CA1-hippocampal pyramidal neurons, which are responsible for memory storage, in an animal model of RA. Moreover, a newly developed reversible inhibitor of MAO-B ameliorated joint inflammation by inhibiting cyclooxygenase (Cox)-2. Therefore, MAO-B can be an effective therapeutic target for joint inflammation and cognitive impairment in patients with RA.

Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via H2O2- production.

Although the pathological contributions of reactive astrocytes have been implicated in Alzheimer's disease (AD), their in vivo functions remain elusive due to the lack of appropriate experimental models and precise molecular mechanisms. Here, we show the importance of astrocytic reactivity on the pathogenesis of AD using GiD, a newly developed animal model of reactive astrocytes, where the reactivity of astrocytes can be manipulated as mild (GiDm) or severe (GiDs). Mechanistically, excessive hydrogen peroxide (H2O2) originated from monoamine oxidase B in severe reactive astrocytes causes glial activation, tauopathy, neuronal death, brain atrophy, cognitive impairment and eventual death, which are significantly prevented by AAD-2004, a potent H2O2 scavenger. These H2O2--induced pathological features of AD in GiDs are consistently recapitulated in a three-dimensional culture AD model, virus-infected APP/PS1 mice and the brains of patients with AD. Our study identifies H2O2 from severe but not mild reactive astrocytes as a key determinant of neurodegeneration in AD.